EICHOR
● Recruiting
Clinical Study of Cord Blood-derived IL-10/IL-15 CD19-CAR NK in the Treatment of Refractory/Relapsed B-cell NHL
Condition: B-cell Non Hodgkin Lymphoma · Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
About this study
To study the safety and effectiveness of cord blood-derived IL-10/IL-15 CD19-CAR NK in patients with B-cell non-Hodgkin's lymphoma
This description comes directly from the study's public registry record.
Talk to the study team
Wenbin Qian, Professor · +8613605801032 · qianwb@zju.edu.cn
Hui Liu, Doctor · 13819198629 · sylen@zju.edu.cn
Always discuss trial participation with your own doctor first.
Locations (1)
| the Second Affiliated Hospital, College of Medicine, Zhejiang University | Hangzhou, Zhejiang, China | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.